Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax

Damjan Avsec, Irena Mlinarič‐Raščan|Cell Death and Disease|2022

Cited by 6